Scholarlink

Background <p>One of the major dilemmas in the treatment of renal cell carcinoma (RCC) is the resistance to therapy that leads to a state of unresponsiveness, which is observed after a certain period. Among the potential causes of this, the impact of autophagy activation and the resulting endoplasmic reticulum (ER) stress due to the accumulation of misfolded or unfolded proteins has not been previously investigated.</p> Methods <p>Patients treated in medical oncology clinics of a total of 3 centers between January 2011 and May 2022 were included. In the pathology preparations of a total of 83 patients diagnosed with metastatic RCC, we examined the effects of autophagy activation induced by mTOR inhibition through the analysis of LC3 and Beclin1 molecules, the differentiation from classical apoptosis pathways with the Bcl-2 level, the hypoxic condition with the HIF-1α level, and ER stress with the eukaryotic initiation factor 2α (eIF2α) level.</p> Results <p>İn our study, found no significant effects of LC3 (<i>p</i> = 0.298), Beclin1 (<i>p</i> = 0.287), Bcl-2 (<i>p</i> = 0.435), and HIF-1α (<i>p</i> = 0.179) levels on either progression-free survival or overall survival. However, eIF2α (<i>p</i> = 0.017) was found to be a significantly decisive factor.</p> Conclusion <p>Based on these results, we suggest that eIF2α may serve as a novel biomarker to predict survival and treatment response in metastatic RCC patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prognostic role of eIF2α protein in metastatic renal cell cancer patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月11日

查看全文
  • Ferhat Ekinci,
  • Hanife Seda Mavili,
  • Nalan Neşe,
  • Atike Pınar Erdoğan,
  • Bilgin Demir,
  • Esin Oktay,
  • Nil Çulhacı,
  • Mehmet Uzun,
  • Aziz Karaoğlu,
  • Kutsal Yörükoğlu,
  • Emine Burçin Tuna,
  • Ahmet Dirican

摘要

Background

One of the major dilemmas in the treatment of renal cell carcinoma (RCC) is the resistance to therapy that leads to a state of unresponsiveness, which is observed after a certain period. Among the potential causes of this, the impact of autophagy activation and the resulting endoplasmic reticulum (ER) stress due to the accumulation of misfolded or unfolded proteins has not been previously investigated.

Methods

Patients treated in medical oncology clinics of a total of 3 centers between January 2011 and May 2022 were included. In the pathology preparations of a total of 83 patients diagnosed with metastatic RCC, we examined the effects of autophagy activation induced by mTOR inhibition through the analysis of LC3 and Beclin1 molecules, the differentiation from classical apoptosis pathways with the Bcl-2 level, the hypoxic condition with the HIF-1α level, and ER stress with the eukaryotic initiation factor 2α (eIF2α) level.

Results

İn our study, found no significant effects of LC3 (p = 0.298), Beclin1 (p = 0.287), Bcl-2 (p = 0.435), and HIF-1α (p = 0.179) levels on either progression-free survival or overall survival. However, eIF2α (p = 0.017) was found to be a significantly decisive factor.

Conclusion

Based on these results, we suggest that eIF2α may serve as a novel biomarker to predict survival and treatment response in metastatic RCC patients.